SCGB1A1 and colorectal cancer: The detection ability of anti-CCSP-2 scFv-FITC for CCSP-2-overexpressing colorectal cancer lesions was evaluated through both topical and i.v. administration in an orthotopic murine model, and we investigated its efficacy with human samples.